{"schema_version":"1","generated_at":"2026-11-11T19:35:04.500Z","data_as_of":null,"url":"https://www.findmykol.com/kol/patrick-mulvaney","json_url":"https://www.findmykol.com/kol/patrick-mulvaney/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"patrick-mulvaney","name":"Patrick Mulvaney","credential":"MD","specialty":"Dermatology","specialty_raw":"Dermatology","therapeutic_area":"Dermatology","therapeutic_areas":["Dermatology"],"institution":"University of Massachusetts Chan Medical School","institution_url":"https://www.findmykol.com/institution/university-of-massachusetts-chan-medical-school","city":"Worcester","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1447630108","orcid":"0000-0003-3796-7146","openalex":"A5103109653"},"summary":"Patrick Mulvaney is a Dermatology physician affiliated with University of Massachusetts Chan Medical School. OpenAlex indexes 27 publications with 442 citations (h-index 9).","overview":null,"focus":{"indications":[],"research_topics":["Dermatology"]},"scholarship":{"works_count":27,"cited_by_count":442,"h_index":9,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"INTERCEPT PHARMACEUTICALS, INC.","program_year":2023,"amount_usd":57.26,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1447630108"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1447630108","source":"payments"},"prescribing":{"data_year":2024,"areas_total":2,"areas_shown":2,"areas":[{"area":"Cancer & immunology","share_pct":63.3,"classes_total":1,"classes":[{"class":"Nucleoside Metabolic Inhibitor","setting":"prescribed","share_pct":63.3,"drugs":[{"name":"Fluorouracil","share_pct":100}],"max_beneficiaries":18}]},{"area":"Anti-infectives","share_pct":36.7,"classes_total":1,"classes":[{"class":"Lincosamide Antibacterial","setting":"prescribed","share_pct":36.7,"drugs":[{"name":"Clindamycin Phosphate","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":27,"shown":5,"withheld":22,"matched_by":"OpenAlex author record","recent":[{"title":"Dermatology residency programs and community engagement: a cross-sectional review of program websites","year":2025,"journal":"Archives of Dermatological Research","source_url":"https://doi.org/10.1007/s00403-024-03672-z","status":"verified"},{"title":"Pediatric Giant Cell Fibroblastoma: A Review of Treatment and Outcomes","year":2025,"journal":"Pediatric Dermatology","source_url":"https://doi.org/10.1111/pde.70116","status":"verified"},{"title":"63481 Pediatric giant cell fibroblastoma: a literature review of management and prognosis","year":2025,"journal":"Journal of the American Academy of Dermatology","source_url":"https://doi.org/10.1016/j.jaad.2025.05.1058","status":"verified"},{"title":"61915 Dermatology residency programs and community engagement: a cross-sectional review of program websites","year":2025,"journal":"Journal of the American Academy of Dermatology","source_url":"https://doi.org/10.1016/j.jaad.2025.05.666","status":"verified"},{"title":"Extensive Perineural Invasion vs Nerve Caliber to Assess Cutaneous Squamous Cell Carcinoma Prognosis","year":2023,"journal":"JAMA Dermatology","source_url":"https://doi.org/10.1001/jamadermatol.2023.3703","status":"verified"}],"source":"works"},"contact":{"address_1":"281 LINCOLN ST","city":"Worcester","state":"MA","zip":"016052138","phone":"508-334-5979","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1447630108","source":"identity"},"similar":[{"name":"Fernando Martinez","slug":"fernando-martinez","institution":"University of Massachusetts Chan Medical School","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/fernando-martinez","json_url":"https://www.findmykol.com/kol/fernando-martinez/profile.json"},{"name":"Kimberly Yonkers","slug":"kimberly-yonkers","institution":"University of Massachusetts Chan Medical School","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/kimberly-yonkers","json_url":"https://www.findmykol.com/kol/kimberly-yonkers/profile.json"},{"name":"Richard Irwin","slug":"richard-irwin","institution":"University of Massachusetts Chan Medical School","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/richard-irwin","json_url":"https://www.findmykol.com/kol/richard-irwin/profile.json"},{"name":"Craig Lilly","slug":"craig-lilly","institution":"University of Massachusetts Chan Medical School","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/craig-lilly","json_url":"https://www.findmykol.com/kol/craig-lilly/profile.json"},{"name":"Robert Modlin","slug":"robert-modlin","institution":"University of California, Los Angeles","specialty":"Dermatology","url":"https://www.findmykol.com/kol/robert-modlin","json_url":"https://www.findmykol.com/kol/robert-modlin/profile.json"},{"name":"Jon Hanifin","slug":"jon-hanifin","institution":"Oregon Health & Science University (OHSU)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/jon-hanifin","json_url":"https://www.findmykol.com/kol/jon-hanifin/profile.json"},{"name":"Heidi Kong","slug":"heidi-kong","institution":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/heidi-kong","json_url":"https://www.findmykol.com/kol/heidi-kong/profile.json"},{"name":"Joel Gelfand","slug":"joel-gelfand","institution":"University of Pennsylvania","specialty":"Dermatology","url":"https://www.findmykol.com/kol/joel-gelfand","json_url":"https://www.findmykol.com/kol/joel-gelfand/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":22}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-05-25","provider_certified":"2021-05-25","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}